Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Benzocaine may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
ORAJEL DENTAL GEL If you are unsure, you should check with your doctor, pharmacist or dentist. Avoid taking hot drinks whilst using Orajel Dental Gel. For adults and children 12 years and over, remove cap, cut open tip of tube and with a clean finger apply an amount of gel the size of a green pea into the tooth cavity. Do not use in children below the age of 12 years. You can use Orajel Dental Gel up to a maximum of 4 times a day. Remember: Orajel Dental Gel is intended for short-term use until you can get to a dentist. It should not be used continuously. If the toothache persists, consult your dentist. If you use more Orajel Dental Gel than you should Contact your nearest hospital casualty department, doctor or dentist immediately. Take this leaflet and any remaining gel with you to show the doctor or dentist.
Like all medicines, Orajel Dental Gel can cause side effects, although not everybody gets them. Stop using the gel and contact your doctor or dentist immediately if any of the following occur:
ORAJEL DENTAL GEL Keep this medicine out of the reach and sight of children. Do not use Orajel Dental Gel if the tube or pack is damaged. Do not use Orajel Dental Gel after the expiry date which is stated on the pack. 6. Further information What Orajel Dental Gel contains Orajel Dental Gel contains 10% w/w of benzocaine as the active ingredient. Orajel Dental Gel also contains macrogol 400, polyethylene glycol 3350, sodium saccharin (E954), sorbic acid (E200), natural spearmint flavor, citric acid and clove oil. What Orajel Dental Gel looks like and contents of the pack Orajel Dental Gel is a colourless gel. It smells like mint. Each tube contains 5.3g of Orajel Dental Gel. Marketing Authorisation Holder and Manufacturer The Marketing Authorisation Holder for Orajel Dental Gel is Church & Dwight UK Ltd., Premier House, Shearway Business Park, Pent Road, Folkestone, Kent CT19 4RJ Orajel is a trademark of Church & Dwight Co., Inc. The manufacturer for Orajel Dental Gel is Laleham Health and Beauty Limited, Mill Lane, Alton, GU34 2PR
Is this leaflet hard to see or read? Phone 0800 028 1454 for help. The leaflet was last updated in May 2019 MA Number: 00203/0227
Orajel Dental Gel comes as gel. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Orajel Dental Gel is benzocaine.
Medicines with the same active substance, strength and form include: Orajel Mouth Gel. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Orajel Dental Gel, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
For temporary rapid relief of toothache pain associated with presence of open carious lesions and direct exposure of a vital dental pulp.
Adults and children aged 12 years and over.
Directions: • Remove cap• Cut off tip of tube on score mark. • With a clean finger or swab apply an amount of gel the size of a green pea into the tooth cavity.• Use up to 4 times daily. • Do not use continuously. If toothache persists, consult your dentist.Not for use in children below the age of 12 years.
Known sensitivity to benzocaine or any of the other ingredients. Not to be used in those individuals suspected of lacking the normal ability to convert methaemoglobin to haemoglobin, see section 4.4 Special warnings and precautions for use and section 4.8 Undesirable effects. Not for use in children below the age of 12 years.
Orajel® is intended for short-term use until a dentist can be consulted. Do not use continuously. Do not exceed recommended dose. The product contains sorbic acid which may cause local skin reactions, e.g. contact dermatitis. Avoid drinking hot liquids whilst using Orajel® . Do not use if there is a family history of methaemoglobinaemia.
Benzocaine, like other derivatives of para-aminobenzoic acid, inhibits the actions of sulphonamides and therefore should not be used concomitantly with any sulphonamide.
There is inadequate evidence of safety of benzocaine in human pregnancy, but it has been in wide use for many years without apparent ill consequences. No clinical data are available on the use of this product during pregnancy and lactation.
No effect on subjects' ability to drive or operate machines.
Application of benzocaine on skin and mucous membranes has resulted in hypersensitivity reactions (burning, stinging, pruritis, erythema, rash and oedema), contact dermatitis and methaemoglobinaemia in a few cases in infants, children and adults. If symptoms persist, or are severe, or are accompanied by fever, headache, breathlessness, nausea and vomiting, consult a doctor. Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
Excessive absorption of benzocaine may produce methaemoglobinaemia in infants, children, and adults. The first clinical signs are cyanotic (greyish) skin discolouration (most notably on mucous membranes) and signs of unusual breathing or breathlessness.Methaemoglobinaemia may be treated by the intravenous administration of 1% methylene blue. Treatment of overdose should be symptomatic and supportive.
Ask anything about Orajel Dental Gel. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.